Chinese companies going global. Global companies capitalizing on the size and growth of the China market. State-owned enterprises. Policy-based state investment. Startup unicorns with Chinese characteristics. There is no shortage of business stories to tell in China.
Ant Group’s listing in Hong Kong likely won’t be completed by the end of October, as originally hoped, due to scrutiny from Chinese regulators. The IPO is unlikely to be derailed, but Ant could soon be the target of largely symbolic sanctions by the Trump administration.
A company that develops gene therapies targeting cancers and congenital disorders is one of many Chinese biotech and pharma startups that are attracting large investments.
China’s imports and exports both surged in September compared with a year before, indicating a continued strong recovery for the Chinese market. Economists surveyed expect Q3 growth to top 5%, nearing 2019 levels.
Miniso, a chain of stores that sell household goods and apparel, has filed for an IPO in New York.
After Ant Group and JD Digits, another Chinese fintech giant has filed for an IPO
Dito has enjoyed a meteoric rise in the Philippines’ stagnant telecom sector, but it hasn’t been without controversy. Critics are concerned about the national security threat posed by one of its partners, China Telecom, which has a 40% share. But does the public share those concerns?
Barely seven years old, Hinova has promising new drugs in the pipeline and plans for an IPO.
Days after Xi Jinping committed China to achieving carbon neutrality by 2060, the country opened its largest solar power plant — and the second largest in the world — with a capacity of 2.2GW.
The Shenzhen-based tech giant continues to snap up game developers around the globe with a major investment in a startup Swedish gaming company.